What is Ibutamoren Mesylate?
Ibutamoren is classified as a non-peptide growth hormone secretagogue and mimics the growth hormone stimulating action of ghrelin. Ibutamoren is considered to be potent, long-acting, and available through oral administration. Clinically, it has been demonstrated to increase the endogenous release of growth hormone (GH) as well as insulin-like growth factor 1 (IGF-1) without the adverse increase of prolactin or cortisol often seen with GHRPs. Additionally, increases in lean body mass can be achieved while lowering LDL cholesterol.
Studies have shown Ibutamoren stimulates brain regions involved with metabolic action, such as the hypothalamus and the pituitary. Ibutamoren may be effective in increasing both muscle mass and bone mineral density, making it a promising therapy for the treatment of frailty and osteoporosis in the elderly.
Patient Benefits Over Time May Include:
Typical Prescribing Protocols:
Ibutamoren is available as a 10 mg or 25 mg oral tablet. As opposed to some of our other sublingual
tablets, it is intended to be swallowed. The tablet can be split in order to deliver a lower dose for a specific patient and is commonly prescribed at bedtime once daily.
The Ibutamoren clinical studies were conducted over short durations of up to 8 weeks. Therefore,
taking an initial IGF-1 baseline and then taking periodic blood tests early on during therapy is
Reach out to your Account Representative today to get more information on Ibutamoren or to place an order. If you don’t know who to contact, call 800.622.4510, or email [email protected].